Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ponatinib is a targeted therapy indicated for the treatment of specific types of···【more】
Release date：2026-01-21Recommended：127
Ponatinib is a targeted therapy for the treatment of specific types of leukemia.···【more】
Release date：2026-01-21Recommended：93
Ponatinib is indicated for the treatment of specific types of chronic myeloid le···【more】
Release date：2026-01-21Recommended：85
Ponatinib is an oral tyrosine kinase inhibitor primarily indicated for the treat···【more】
Release date：2026-01-20Recommended：106
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) primarily indica···【more】
Release date：2026-01-20Recommended：144
Ponatinib is an oral tyrosine kinase inhibitor primarily indicated for the treat···【more】
Release date：2026-01-20Recommended：115
Ponatinib is indicated for the treatment of patients with chronic-phase chronic ···【more】
Release date：2026-01-20Recommended：73
Ponatinib is a third-generation tyrosine kinase inhibitor (TKI), primarily indic···【more】
Release date：2026-01-20Recommended：92
The price of ponatinib varies depending on the region, specification, purchase c···【more】
Release date：2026-01-20Recommended：100
Ponatinib is a targeted therapy indicated for specific types of leukemia, such a···【more】
Release date：2026-01-20Recommended：96
Ponatinib is an oral targeted drug specifically indicated for the treatment of c···【more】
Release date：2026-01-20Recommended：101
Takeda Pharmaceutical Company Limited (Takeda) recently announced that the U.S. ···【more】
Release date：2026-01-20Recommended：116
